Loading clinical trials...
Loading clinical trials...
Future patients might benefit from a combination of linezolid (LIN) and clarithromycin (CLA) in the treatment of Multidrug-resistant and Extensively Drug-resistant Tuberculosis (MDR/XDR-TB) due to pos...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
University Medical Center Groningen
NCT04260477 · Multidrug-resistant Tuberculosis, Pulmonary Tuberculosis, and more
NCT07393438 · Multidrug-Resistant Tuberculosis, Rifampicin-resistant Tuberculosis, and more
NCT03086486 · Tuberculosis, Pulmonary, Tuberculosis, Multidrug-Resistant, and more
NCT00685360 · Tuberculosis, Pulmonary, Tuberculosis, Multidrug Resistant, and more
NCT02984579 · Multidrug-Resistant Tuberculosis, Isoniazid Resistant Pulmonary Tuberculosis, and more
Tuberculosis Center Beatrixoord
Haren, Provincie Groningen
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions